Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2
Watchlist
Price: 0.3848 EUR
Market Cap: €4.6B

Shandong Weigao Group Medical Polymer Co Ltd
Investor Relations

Shandong Weigao Group Medical Polymer makes hospital consumables and medical devices used in everyday care. Its products include infusion sets, syringes, needles, blood collection items, dialysis and blood purification products, orthopedic implants, and other disposable medical supplies that hospitals, clinics, and healthcare distributors buy for routine treatment and procedures. The company earns money by selling these products to medical institutions and distributors, mainly in China and also in overseas markets. A large part of its business comes from repeat purchases, because many of its products are used once or need regular replacement in hospitals and treatment centers. What makes Weigao important is that it sits close to the point of care: it supplies the basic tools doctors and nurses use every day. That gives it a steady role in the healthcare supply chain, with a mix of low-cost consumables and more specialized devices that serve different parts of the hospital market.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Rinan Cong
Chief Executive Officer
No Bio Available
Mr. Xue Feng Wu
Chief Financial Officer
No Bio Available
Ms. Xia Yan
Non-Executive Director
No Bio Available
Mr. Daoming Wang
Executive Director
No Bio Available
Ms. Miu Ling Wong ACIS, FCIS, FCS
Company Secretary
No Bio Available

Contacts

Address
SHANDONG
Weihai
No.18 Xingshan Road,Torch Hi-Tech Industry Development Zone
Contacts
+866315621999.0
www.weigaoholding.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett